Previous Page  14 / 17 Next Page
Information
Show Menu
Previous Page 14 / 17 Next Page
Page Background

Notes:

Volume 2, Issue 3 2017

Journal of Medical Oncology and Therapeutics

Dermatologists & Melanoma 2017

August 31-September 01, 2017

Page 66

&

2

nd

Euro-Global Congress on

August 31-September 01, 2017 London, UK

12

th

Global Dermatologists Congress

Melanoma and Skin Diseases

Primary dermal melanoma (PDM): Experience and insights from a large, single surgeon's series in

a tertiary center

Zamir H

1

, Feinmesser M

2,3

and

Gutman H

2,3

1

Rambam Health Care Campus and the Bruce Rappaport Faculty of Medicine, Israel

2

Rabin Medical Center, Israel

3

Tel Aviv University, Israel

Background:

PDM is a rare variant of melanoma. It is confined to the dermis and/or subcutis without epidermal component.

Hence, histologically alone, it cannot be distinguished from a melanoma metastasis. Careful clinical history, examination and

proper imaging are required to exclude metastatic disease. Diagnosing such a lesion as PDM or as a metastasis has significant

impact on the proper management and on the prognosis. Our experience and insights cast some light on this problematic

clinical situation.

Methods:

We retrieved all 36 clinically diagnosed PDM patients from our prospectively collected database of 1600 melanoma

patients surgically treated in a tertiary melanoma center between 1995 and 2015. Strict focused pathology revision excluded

23 patients who failed to meet all criteria for PDM set forth by Swetter et. al. Thirteen0 patients were in-depth investigated

regarding clinical, histopathological parameters, surgical treatment and outcome.

Results:

13 PDMs, median "thickness" – 5.5 (range 2 to 11) mm, median mitotic rate 4 (range 0 to 17)/mmsq, formed this

series. Eleven patients (84.6%) are still alive after median follow up of 56 (range 12 to 120) months. Three of 13 patients had a

positive sentinel lymph node followed by completion dissection.

Discussion:

It seems that when PDM is diagnosed, it can be successfully treated as a primary melanoma (rather than a

metastasis) including Sentinel node sampling and completion dissection. The actual "thickness" of these melanomas, as well as

their mitotic rates, are associated with better prognosis than same-thickness cutaneous melanomas.

Conclusions:

Diagnosing PDM demands careful clinical and histological reviews. PDM has favorable outcome compared to

primary cutaneous same –thickness melanoma. Wide local excision and Sentinel lymph node biopsy seem appropriate and

worthwhile, once these lesions are deemed primary melanomas.

Biography

Hadas Zamir,Working at Department of Dermatology at Rambam Health Care Campus , Bruce Rappaport Faculty of Medicine, Haifa, Israel. Hadas Zamir has

Published journals in reputed sites. His Intrests in Dermatology & Melanoma research are currently going on.

hadas.zamir@gmail.com

Zamir H et al., J Med Oncl Ther 2017, 2:3